Literature DB >> 8942410

A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids.

M Steiner1, A H Khan, D Holbert, R I Lin.   

Abstract

A double-blind crossover study comparing the effect of aged garlic extract with a placebo on blood lipids was performed in a group of 41 moderately hypercholesterolemic men [cholesterol concentrations 5.7-7.5 mmol/L (220-290 mg/dL)]. After a 4-wk baseline period, during which the subjects were advised to adhere to a National Cholesterol Education Program Step I diet, they were started on 7.2 g aged garlic extract per day or an equivalent amount of placebo as a dietary supplement for a period of 6 mo, then switched to the other supplement for an additional 4 mo. Blood lipids, blood counts, thyroid and liver function measures, body weight, and blood pressure were followed over the entire study period. The major findings were a maximal reduction in total serum cholesterol of 6.1% or 7.0% in comparison with the average concentration during the placebo administration or baseline evaluation period, respectively. Low-density-lipoprotein cholesterol was also decreased by aged garlic extract, 4% when compared with average baseline values and 4.6% in comparison with placebo period concentrations. In addition, there was a 5.5% decrease in systolic blood pressure and a modest reduction of diastolic blood pressure in response to aged garlic extract. We conclude that dietary supplementation with aged garlic extract has beneficial effects on the lipid profile and blood pressure of moderately hypercholesterolemic subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8942410     DOI: 10.1093/ajcn/64.6.866

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  30 in total

1.  An evidence-based review of the 10 most commonly used herbs.

Authors:  C Mar; S Bent
Journal:  West J Med       Date:  1999-09

Review 2.  Soy, garlic, and ginkgo biloba: their potential role in cardiovascular disease prevention and treatment.

Authors:  Christopher D Gardner; Mark Messina; Larry D Lawson; John W Farquhar
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

Review 3.  Types of garlic and their anticancer and antioxidant activity: a review of the epidemiologic and experimental evidence.

Authors:  Zeinab Farhat; Pamela A Hershberger; Jo L Freudenheim; Manoj J Mammen; Rachael Hageman Blair; Diana S Aga; Lina Mu
Journal:  Eur J Nutr       Date:  2021-02-04       Impact factor: 5.614

Review 4.  A review on the effects of Allium sativum (Garlic) in metabolic syndrome.

Authors:  A Hosseini; H Hosseinzadeh
Journal:  J Endocrinol Invest       Date:  2015-06-03       Impact factor: 4.256

5.  Role of nutraceuticals in human health.

Authors:  Lipi Das; Eshani Bhaumik; Utpal Raychaudhuri; Runu Chakraborty
Journal:  J Food Sci Technol       Date:  2011-02-26       Impact factor: 2.701

6.  Garlic ameliorates hyperlipidemia in chronic aminonucleoside nephrosis.

Authors:  J Pedraza-Chaverrí; O N Medina-Campos; M A Granados-Silvestre; P D Maldonado; I M Olivares-Corichi; R Hernández-Pando
Journal:  Mol Cell Biochem       Date:  2000-08       Impact factor: 3.396

Review 7.  Garlic for the prevention of cardiovascular morbidity and mortality in hypertensive patients.

Authors:  Sarah N Stabler; Aaron M Tejani; Fong Huynh; Claire Fowkes
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 8.  Complementary and alternative medicine in diabetes care.

Authors:  Monica M DiNardo; Jolynn M Gibson; Lara Siminerio; Allison R Morell; Edward S Lee
Journal:  Curr Diab Rep       Date:  2012-12       Impact factor: 4.810

9.  A review of studies of garlic (Allium sativum) on serum lipids and blood pressure before and after 1994: does the amount of allicin released from garlic powder tablets play a role?

Authors:  Marc P McRae
Journal:  J Chiropr Med       Date:  2005

10.  Anti-atherosclerotic therapy based on botanicals.

Authors:  Alexander N Orekhov; Igor A Sobenin; Nikolay V Korneev; Tatyana V Kirichenko; Veronika A Myasoedova; Alexandra A Melnichenko; Mercedes Balcells; Elazer R Edelman; Yuri V Bobryshev
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.